Analysts expect HUTCHMED (China) Ltd to report revenue of 649.75 M for 2026, against a range of 605.74 M to 693.75 M. The most recent reported year, 2025, came in at 548.51 M, a 3.5% beat against the 530.01 M consensus.
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 356.13 M | 426.41 M | 838.00 M | 630.20 M | 548.51 M | - | - | ||
| High Estimate | 387.68 M | 424.79 M | 900.05 M | 678.38 M | 581.62 M | 693.75 M | 723.36 M | ||
| Low Estimate | 322.35 M | 353.54 M | 793.23 M | 562.94 M | 478.39 M | 605.74 M | 630.45 M | ||
| Consensus Estimate | 355.01 M | 389.16 M | 846.64 M | 620.66 M | 530.01 M | 649.75 M | 676.91 M |
Analysts expect HUTCHMED (China) Ltd to report earnings per share of 0.26 for 2026, against a range of 0.24 to 0.28. The most recent reported year, 2025, came in at 2.60, a 8.1% miss against the 2.83 consensus.
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | -1.25 | -2.15 | 0.60 | 0.20 | 2.60 | - | - | ||
| High Estimate | -1.63 | -2.07 | 0.05 | -0.03 | 3.00 | 0.28 | 0.46 | ||
| Low Estimate | -1.85 | -2.23 | 0.05 | -0.03 | 2.66 | 0.24 | 0.38 | ||
| Consensus Estimate | -1.74 | -2.15 | 0.05 | -0.03 | 2.83 | 0.26 | 0.42 |